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Abstract: We present a new probe for radiotracer detection in vivo. The device is based
on silicon photomultipliers coupled with a scintillator and wirelessly compensated for supply
voltage and temperature variations. The probe is positron sensitive.
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1. Introduction
During the last decades, positron emission tomography (PET) has been established as the imaging technique of choice
to identify and localise tumours and metastases prior to surgical interventions. Unfortunately, PET scans require a large
machine, which cannot be used in the operating theatre. During the operation, the PET image recorded beforehand
(fig. 1) can only give approximate information of the actual location of the tumour, as organs in the human body
continuously move. The success of an intervention therefore depends to a large extend on accurately finding neoplastic
lymph nodes and metastatic tissues and on choosing the resection margins. This may be difficult in case of prior surgery
or chemo- or radiation therapy.
 
Fig. 5. Preoperative hybrid CT (left) PET/CT (middle) and PET (right) imaging of a metastatic right iliac lymph 
node (arrow) to be removed. 
 
 
 
Fig. 6. Postoperative verification with the !
+
 probe of the explanted neoplastic lymph node. 
 
 
 
 
Fig. 7. Probe prototype for laparoscopic interventions. 
Figure 1. Metastatic right internal iliac lymph node in a 64-year-old men operated 2 years ago from a right thigh
melanoma 3.1mm Breslow index. Preoperative hybrid CT (left), PET/CT (middle) and PET (right)
To overcome this limitation, we propose to use a sensor that is small enough to be used during operations [1], while
being sensitive to the same radioactive tracers utilised in PET scans [2]. This limits the radioactive dose to which
the patient is exposed, to the amount required for a PET scan. A very common radiotracer is 18F-fluorodeoxyglucose
(FDG), a modified glucose analogue emitting β+ radiation (positrons). FDG is metabolised in the same way as nor-
mal glucose but gets trapped and accumulates in the cells, the rest being eliminated by the kidneys, which entails a
considerable background signal in the urinary system. In order to have a meaningful measurement, the probe needs
to have a large spatial resolution and low noise; it needs to withstand standard sterilisation procedures. As the probe
is wireless, it is sufficient to sterilise only the handheld part which is in contact with the patient, thus significantly
simplifying pre-operative handling.
2. Prototype
The prototype demonstrates the concept of detecting β+ radiation with very low noise and high sensitivity in a wireless,
handheld probe during operations. The β+ particles can either hit the detector and generate a signal or annihilate
and create two 511keV photons, which can occasionally produce a signal in the scintillator. The visible photons are
detected with two silicon photomultipliers, operated in coincidence mode in order to reduce the dark count rate to
negligible levels [3]. The coincidence principle takes advantage of the fact that the element with the highest dark count
rate is the photomultiplier, not the scintillator. Monitoring the very same scintillator with two different, independent
photomultipliers will lead to a signal in both SiPMs in case of a real particle detection, while SiPM dark count will
show as uncorrelated signals.
The block diagram of the probe, excluding the external control system, is shown in fig. 2.
The complete probe, including the module for wireless feedback used to stabilise the behaviour of the probe in
an environment with temperature variations, is shown in fig. 3. It consists of a 44mm long tip with a small diameter
(9mm), containing a scintillator and the photomultipliers, and an end part with a larger diameter (22mm), which is
housing most of the electronics. The surgeon holds the probe at the end part like a white-board marker pen. The total
mass of a ready-to-use short probe is 80g, including batteries.
S
c i
n t
i l l
a t
o r
S
i P
M
S
i P
M
Bias voltage 
generation
Shaper
Shaper
Coincidence 
logic Digitisation
Microcontroller for 
readout and 
slow control 
BlueTooth 
module
Temperature 
sensor
Figure 2. Block diagram of the probe
Figure 3. Probe prototype (left), sensor head for coincidence measurement (right)
3. Clinical Use
The first pilot clinical trials have been successful in a number of operations involving metastatic lymph nodes (fig. 4).
For operations with large incisions and easily accessible regions of interest, the short version of the probe (fig. 3) is
used. Further trials are expected to start in the second quarter of 2011. By then, a variant of the probe, specially adapted
to laparoscopic operations, will be available. It contains the same electronics and provides the same functionality. The
end part remains unchanged, while the tip with a diameter of 9mm is elongated to 250mm, so that it can be used in a
mediastinoscope.
Figure 4. Early clinical trials: Surgical ablation of the metastatic lymph node
A: General setting in the operating room
B: Close view of the peroperative use of the β+ probe
C: Ex vivo verification of the stripped right internal iliac lymph node chain
showing only one PET+ lymph node, which was confirmed by histopathology
as the only node with melanoma metastatic cells out of 19 removed lymph
nodes.
As further refinement, adding a 3D positioning system to the probe would help associating measurements with the
probe position at any moment in time, allowing to generate images of the region of interest.
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